Cleo Diagnostics Ltd News

Cleo Diagnostics Ltd: Cleo Commences US Regulatory Process with FDA

Jun 26 07:03

Cleo Diagnostics Ltd: Application for quotation of securities - COV

Jun 24 14:59

Cleo Diagnostics Ltd: Restricted securities to be released from escrow

Jun 14 14:13

Cleo Diagnostics Ltd: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark

May 29 07:03

Cleo Diagnostics Ltd: Quarterly activities and cashflow report

Apr 29 08:10

Cleo Diagnostics Ltd: COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials

Apr 11 07:31

Cleo Diagnostics Ltd: CLEO Appoints Partner to Commence U.S. Market Access Program

Apr 2 09:11

Cleo Diagnostics Ltd: Peer-Review Supports CLEOs Ovarian Cancer Detection Tech

Mar 25 06:45

Cleo Diagnostics Ltd: Appendix 4D and Half Yearly Accounts

Feb 29 14:20

Cleo Diagnostics Ltd: Corporate Presentation February 2024

Feb 20 06:48

Cleo Diagnostics Ltd: Cleo Completes Design Transfer

Feb 12 07:01

Cleo Diagnostics Ltd: Quarterly activities and cashflow report

Jan 31 13:14

Cleo Diagnostics Ltd: Results of Annual General Meeting

Nov 22, 2023 14:40

Cleo Diagnostics Ltd: Application for quotation of securities - COV

Nov 6, 2023 14:54

Cleo Diagnostics Ltd: Completion of First Triage Test Clinical Validation Study

Nov 6, 2023 07:07

Cleo Diagnostics Ltd: Trading Halt

Nov 3, 2023 07:47

Cleo Diagnostics Ltd: Pause in Trading

Nov 3, 2023 07:16

Cleo Diagnostics Ltd: Quarterly activities and cashflow report

Oct 30, 2023 06:41

Cleo Diagnostics Ltd: Restricted securities to be released from escrow

Oct 27, 2023 12:43

Cleo Diagnostics Ltd: Application for quotation of securities - COV

Oct 13, 2023 13:25